solitary plasmocytoma is rarely located in the cranial vault. we report one case of solitary plasmacytoma of the skull and discuss the clinical features and treatment of this uncommon tumor in the light of the published cases. a 46-year-old moroccan male, without previous history consulted for a swelling in medial frontal and paramedian region. on clinical examination the clinical examination r...

Rationale: Gastrointestinal solitary extramedullary plasmacytoma (EMP) is rare, just occupies about 5% of all EMPs. The most common site is small intestine followed by stomach. The colorectal incidence is much rare. Patient concerns: A 63-year-old female had an episodic pain around the umbilicus for about one week. The hyperemia and edema in the ileocecal mucosa were found in colonoscopy, and t...

The prognosis of solitary plasmacytoma varies greatly, with some patients recovering after surgical removal or local fractional radiation therapy, and others progressing to multiple myeloma years later. Primary detection of progression to multiple myeloma is important in the treatment of solitary plasmacytoma. There have been several analyses of the risk factors involved in the early progressio...

Solitary plasmacytoma of the skull is very rare and only a few cases have been reported in the English literature. Skull solitary plasmacytoma tends to disseminate or progress to multiple myeloma (MM) during follow-up. If the skull lesion is isolated, couple with tenderness and marked swelling in the area, plasmacytoma should be considered, especially for the lesion showing isointense with the ...

Plasmacytoma is a rare disease, which afflicts 2 to 3 people per every 100,000 of the general population. Solitary plasmacytoma accounts for 5% of the plasma cell neoplasm. Solitary plasmacytoma of the bone appears more vividly in the axial skeleton (25-60%), which has the red marrow and usually affects the thoracic vertebrae. We report a case of 54-year-old man who has a chest pain on the righ...

Introduction: Plasmacytoma is a localized collection of malignant plasma cells. The disease can be divided into solitary plasmacytoma of the bone (SPB) and extramedullary plasmacytoma (EMP), both of which are distinct entities. An EMP, the rarer of the two, has soft tissue infiltration by clonal plasma cells without any occult or systemic myeloma. Whereas, SPB has a solitary lytic bone lesion w...